SYNIMMUNE GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Subsidiary
- Established
- 2010-07-07
- Employees
- -
- Market Cap
- -
- Website
- http://www.synimmune.de
FLYSYN in MRD Positive AML
Phase 1
Completed
- Conditions
- Acute Myeloid Leukemia
- Interventions
- Biological: FLYSYN
- First Posted Date
- 2016-06-02
- Last Posted Date
- 2023-12-28
- Lead Sponsor
- Synimmune GmbH
- Target Recruit Count
- 31
- Registration Number
- NCT02789254
- Locations
- 🇩🇪
University Hospital Tuebingen, Tuebingen, Baden-Wuerttemberg, Germany
🇩🇪Hannover Medical School, Hannover, Niedersachsen, Germany
🇩🇪University Hospital of Heidelberg, Heidelberg, Germany
© Copyright 2025. All Rights Reserved by MedPath